← Back to Search

Mupirocin Ointment for Radiation Skin Damage

Phase 2 & 3
Waitlist Available
Led By Beth McLellan, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of a solid tumor of the breast or head and neck with plans for fractionated radiation therapy (≥ 15 fractions) with curative intent
Age ≥ 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the first week (week 1) to the last week of treatment (study week depends on patient's length of treatment), approximately 5 to 8 weeks
Awards & highlights

Study Summary

This study is evaluating whether a nasal and skin decolonization may help prevent radiation dermatitis for patients with head and neck or breast cancer.

Eligible Conditions
  • Radiation Skin Damage

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the first week (week 1) to the last week of treatment (study week depends on patient's length of treatment), approximately 5 to 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and from the first week (week 1) to the last week of treatment (study week depends on patient's length of treatment), approximately 5 to 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Median Change in Quality of Life Scoring Rated by the Skindex-16 Dermatological Survey
Number of Participants With Incidence of High Grade Radiation Dermatitis

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment ArmExperimental Treatment2 Interventions
The purpose of this study is to determine whether bacterial decolonization of the nares and skin prior to treatment with radiotherapy (RT) for patients with cancers of the head and neck or breast, can prevent high-grade radiation dermatitis (RD) and improve quality of life. This study is being conducted because prior studies from this research group have found bacterial colonization in the nose prior to initiation of RT to be associated with an increased risk of high-grade RD. Patients in the treatment arm will receive pretreatment with mupirocin ointment to the nares and chlorhexidine wash to the body while patients in the control arm will receive standard of care treatment. Bacterial cultures will be taken from the nares and skin, and participants will also complete a quality of life questionnaire before and after RT.
Group II: ControlActive Control1 Intervention
Patients in the control arm will be treated according to standard of care without any radiation dermatitis prophylaxis.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Chlorhexidine gluconate solution
2019
Completed Phase 3
~160
Mupirocin Ointment
2019
Completed Phase 3
~80

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
441 Previous Clinical Trials
582,116 Total Patients Enrolled
Beth McLellan, MD5.01 ReviewsPrincipal Investigator - Montefiore Medical Center
Montefiore Medical Center
1 Previous Clinical Trials
30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Bacterial Decolonization to Prevent Radiation Dermatitis
Beth McLellan 2019. "Bacterial Decolonization to Prevent Radiation Dermatitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03883828.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top